grants

Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.

UCLA Fielding School of Public Health professor Marc Suchard will co-lead the effort, which has received funding from the National Institutes of Health.

The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.

A team led by Andrea Bertozzi and Mason Porter will use mathematical modeling to provide insights to those developing strategies to mitigate the disease’s spread.

Participants have interned at the Metropolitan Museum of Art, the Autry Museum and the Smithsonian American Art Museum.

The NIH awarded $27.2 million to UCLA to lead the new phase of an effort to enhance diversity in the biomedical workforce.

Funds from California’s stem cell agency will support research on a blinding eye disease, cancer and an immune disorder.

The funds will help advance work in diagnosis, prognosis and treatment of the disease

A separate grant of $3.3 million will fund a study on the effectiveness of text messages for helping people adhere to their treatment regimens.

The new Biodesign Hub in Los Angeles will focus on developing medical technology and digital health tools.

The funds will support a phase 1 clinical trial of a treatment for advanced sarcomas and other cancers.

The $3.7 million, three-year grant will go toward research aimed to develop imaging technology that allows the recording of tens of thousands of neurons to better understand how the brain goes awry in disease.

The award by the California Institute for Regenerative Medicine brings hope to those dealing with untreatable blindness such as macular degeneration.

Arcadia, a charitable fund of Lisbet Rausing and Peter Baldwin, gives $5.5 million to support Documenting Global Voices.

Researchers from the School of Dentistry and the David Geffen School of Medicine will use a technology created in the lab of Dr. David Wong from the dental school.

The state-funded IMPACT program provides access to free treatment for uninsured and underinsured men in California.

The awards are part of an L.A. Care initiative intended to recruit more physicians to serve Los Angeles County’s most vulnerable residents.

The Synthetic Control Across Length-scales for Advancing Rechargeables center will help accelerate research on new types of chemistry and materials that can help improve batteries’ capacity, stability and safety.

The new work will continue a study that began in 2013 with a $7 million grant from the National Institute on Drug Abuse.

The awards, which total nearly $2.3 million, will support work by professors at the UCLA Fielding School of Public Health and the UCLA Graduate School of Education and Information Studies.

An earlier $2 million grant from the foundation established the California Policy Lab in 2017.

The award from the Patient-Centered Outcomes Research Institute will be used to compare care delivered through a health system with care that occurs in a community-based setting.

The five-year award is intended to fund a research project that addresses the needs of both patients and caregivers.

The five-year project funded by the National Institute of Allergy and Infectious Diseases will involve three projects to investigate factors that accelerate and prevent the re-emergence of HIV.

Delta Dental of California awarded the grant, which will support student dentists to care for some of the most vulnerable patients in the state.